Breaking News
Sort by:
Top Post
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
Annovis Bio Announces New Appointments to Strengthen Its Senior Leadership Team
Annovis Bio, a clinical-stage drug platform company addressing neurodegenerative diseases, has announced key additions to […]
Lyndra Therapeutics Announces New Board Members and Chief Technology Officer
Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the appointment of […]
BICO Group Appoints Marius Balger as New COO
BICO Group is pleased to announce the appointment of Marius Balger as Chief Operating Officer […]
NHS England Appoints Leading Clinicians To Board
NHS England has added a wealth of clinical expertise and experience to its board with […]
CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
NMD Pharma Appoints Mike Heffernan as Chairman of Board of Directors
NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular […]
Vivera Welcomes CPG Leader Karen Antonio to its Advisory Board
Direct-to-consumer, consumer packaged goods (CPG), business development, and retail distribution expert Karen Antonio has joined Vivera […]
CN Bio Appoints Dr Paul Brooks as Chief Executive Officer
CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems […]
Eiger BioPharmaceuticals Announces Leadership Change
Eiger BioPharmaceuticals, a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis […]
Almirall Appoints Mercedes Diz as VP, Corporate Strategy
Almirall, a global biopharmaceutical company focused on skin health, today announced that Mercedes Diz will […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more